Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1537058

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1537058

Anti-Embolism Stockings Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4900
PDF & Excel (Multi User License)
USD 6400
PDF & Excel (Corporate User License)
USD 7400

Add to Cart

Persistence Market Research has recently released a comprehensive report on the worldwide market for anti-embolism stockings. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Anti-Embolism Stockings Market

  • Market Size (2024E): USD 794 Million
  • Projected Market Value (2032F): USD 1199.6 Million
  • Global Market Growth Rate (CAGR 2024 to 2032):5.3%

Anti-Embolism Stockings Market - Report Scope:

Anti-embolism stockings play a crucial role in the prevention of deep vein thrombosis (DVT) and other venous thromboembolic events (VTEs). These stockings apply graduated compression to the legs, enhancing blood circulation and reducing the risk of clot formation. The anti-embolism stockings market caters to hospitals, clinics, outpatient surgical centers, and homecare settings, offering a range of stocking types and compression levels to meet diverse patient needs. Market growth is driven by increasing awareness of VTE prevention, rising incidences of chronic venous disorders, and advancements in stocking materials and designs.

Market Growth Drivers:

The global anti-embolism stockings market is propelled by several key factors, including the growing awareness about VTE prevention among healthcare providers and patients. The rising number of surgical procedures and the increasing prevalence of conditions such as obesity, cancer, and cardiovascular diseases, which heighten the risk of DVT, further drive market expansion. Technological advancements, such as the development of stockings with improved breathability, comfort, and antimicrobial properties, enhance patient compliance and treatment outcomes, fostering market growth. Moreover, the growing adoption of home-based care and preventive healthcare practices creates new avenues for market players to reach a broader patient population.

Market Restraints:

Despite promising growth prospects, the anti-embolism stockings market faces challenges related to patient compliance, reimbursement policies, and competition from alternative VTE prevention methods. Patient adherence to wearing compression stockings consistently can be low due to discomfort or inconvenience, impacting treatment efficacy. Limited reimbursement coverage for anti-embolism stockings and the high cost of premium products pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these challenges requires education initiatives to improve patient compliance and advocacy for better reimbursement policies to promote access to effective VTE prevention solutions.

Market Opportunities:

The anti-embolism stockings market presents significant growth opportunities driven by demographic trends, technological innovations, and evolving healthcare delivery models. The aging global population and the rising incidence of chronic diseases create a growing demand for preventive healthcare products, including anti-embolism stockings. The integration of smart textiles and digital health technologies, such as wearable sensors for real-time monitoring of compression levels and patient compliance, enhances product functionality and patient outcomes. Strategic partnerships, investment in research and development, and the introduction of cost-effective, user-friendly anti-embolism stockings are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic anti-embolism landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the anti-embolism stockings market globally?
  • Which stocking types and applications are driving anti-embolism stockings adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the anti-embolism stockings market?
  • Who are the key players contributing to the anti-embolism stockings market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global anti-embolism stockings market?

Competitive Intelligence and Business Strategy:

Leading players in the global anti-embolism stockings market, including Sigvaris, Medi GmbH & Co. KG, and BSN Medical Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced anti-embolism stockings with enhanced comfort, durability, and therapeutic efficacy, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving anti-embolism landscape.

Key Companies Profiled:

  • Medtronic (Covidien)
  • Sigvaris
  • Medi
  • BSN Medical
  • Juzo
  • 3M
  • Bauerfeind AG
  • Thuasne Corporate
  • Pretty Legs Hosiery
  • Salzmann-Group
  • Paul Hartmann
  • Cizeta Medicali
  • Belsana Medical
  • Gloria Med

Anti-Embolism Stockings Industry Research Segmentation

By Product:

  • Calf-length
  • Thigh-length

By Demography:

  • Men
  • Women

By End User:

  • Ambulatory Patients
  • Post-operative Patients
  • Pregnant Women

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)
Product Code: PMRREP33355

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies by Manufacturers
  • 4.2. Regulatory Landscape
  • 4.3. Value Chain Analysis
  • 4.4. Product Adoption Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Historical Growth of Top Companies
    • 5.2.2. Adoption Rate
    • 5.2.3. Technology Advancements
    • 5.2.4. Increasing Deep Vein Thrombosis Cases
    • 5.2.5. Product Pricing
    • 5.2.6. Favorable Reimbursement Policies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Demography
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 10.3.1. Calf Length
    • 10.3.2. Thigh Length
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Demography

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Demography, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Demography, 2024-2032
    • 11.3.1. Men
    • 11.3.2. Women
  • 11.4. Market Attractiveness Analysis By Demography

12. Global Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By End User, 2024-2032
    • 12.3.1. Ambulatory Patients
    • 12.3.2. Post-Operative Patients
    • 12.3.3. Pregnant Women
    • 12.3.4. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Demography
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Demography
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Demography
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Demography
        • 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Demography
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Demography
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Demography
        • 15.7.1.2.3. By End User
    • 15.7.2. Mexico Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Demography
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Demography
        • 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. U.K.
      • 16.3.1.2. Germany
      • 16.3.1.3. Italy
      • 16.3.1.4. France
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Demography
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Demography
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. U.K. Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Demography
        • 16.7.1.2.3. By End User
    • 16.7.2. Germany Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Demography
        • 16.7.2.2.3. By End User
    • 16.7.3. Italy Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Demography
        • 16.7.3.2.3. By End User
    • 16.7.4. France Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Demography
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Market Analysis
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Product
        • 16.7.5.2.2. By Demography
        • 16.7.5.2.3. By End User
    • 16.7.6. Russia Market Analysis
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Product
        • 16.7.6.2.2. By Demography
        • 16.7.6.2.3. By End User
    • 16.7.7. BENELUX Market Analysis
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Product
        • 16.7.7.2.2. By Demography
        • 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Demography
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Demography
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. China Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Demography
        • 17.7.1.2.3. By End User
    • 17.7.2. Japan Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Demography
        • 17.7.2.2.3. By End User
    • 17.7.3. South Korea Market Analysis
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Product
        • 17.7.3.2.2. By Demography
        • 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Demography
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Demography
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. India Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Demography
        • 18.7.1.2.3. By End User
    • 18.7.2. Indonesia Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Demography
        • 18.7.2.2.3. By End User
    • 18.7.3. Malaysia Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Demography
        • 18.7.3.2.3. By End User
    • 18.7.4. Thailand Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Demography
        • 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Demography
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Demography
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Market Analysis
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Product
        • 19.7.1.2.2. By Demography
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Market Analysis
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Product
        • 19.7.2.2.2. By Demography
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Demography
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Demography
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Market Analysis
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Product
        • 20.7.1.2.2. By Demography
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkiye Market Analysis
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Product
        • 20.7.2.2.2. By Demography
        • 20.7.2.2.3. By End User
    • 20.7.3. South Africa Market Analysis
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Product
        • 20.7.3.2.2. By Demography
        • 20.7.3.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. MD
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. Key Financials
      • 22.3.1.6. SWOT Analysis
      • 22.3.1.7. Strategy Overview
    • 22.3.2. Medtronic(Covidien)
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. Key Financials
      • 22.3.2.6. SWOT Analysis
      • 22.3.2.7. Strategy Overview
    • 22.3.3. Sigvaris, Medi
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. Key Financials
      • 22.3.3.6. SWOT Analysis
      • 22.3.3.7. Strategy Overview
    • 22.3.4. BSN Medical
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. Key Financials
      • 22.3.4.6. SWOT Analysis
      • 22.3.4.7. Strategy Overview
    • 22.3.5. Juzo
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. Key Financials
      • 22.3.5.6. SWOT Analysis
      • 22.3.5.7. Strategy Overview
    • 22.3.6. 3M
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. Key Financials
      • 22.3.6.6. SWOT Analysis
      • 22.3.6.7. Strategy Overview
    • 22.3.7. Bauerfeind AG
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. Key Financials
      • 22.3.7.6. SWOT Analysis
      • 22.3.7.7. Strategy Overview
    • 22.3.8. Thuasne Corporate
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. Key Financials
      • 22.3.8.6. SWOT Analysis
      • 22.3.8.7. Strategy Overview
    • 22.3.9. Pretty Legs Hosiery
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. Key Financials
      • 22.3.9.6. SWOT Analysis
      • 22.3.9.7. Strategy Overview
    • 22.3.10. Salzmann-Group
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. Key Financials
      • 22.3.10.6. SWOT Analysis
      • 22.3.10.7. Strategy Overview
    • 22.3.11. Paul Hartmann
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. Key Financials
      • 22.3.11.6. SWOT Analysis
      • 22.3.11.7. Strategy Overview
    • 22.3.12. Cizeta Medicali
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. Key Financials
      • 22.3.12.6. SWOT Analysis
      • 22.3.12.7. Strategy Overview
    • 22.3.13. Belsana Medical
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.13.4. Sales Footprint
      • 22.3.13.5. Key Financials
      • 22.3.13.6. SWOT Analysis
      • 22.3.13.7. Strategy Overview
    • 22.3.14. Gloria Med
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.14.4. Sales Footprint
      • 22.3.14.5. Key Financials
      • 22.3.14.6. SWOT Analysis
      • 22.3.14.7. Strategy Overview
    • 22.3.15. Zhende Medical Group
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.15.4. Sales Footprint
      • 22.3.15.5. Key Financials
      • 22.3.15.6. SWOT Analysis
      • 22.3.15.7. Strategy Overview
    • 22.3.16. Maizi
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.16.4. Sales Footprint
      • 22.3.16.5. Key Financials
      • 22.3.16.6. SWOT Analysis
      • 22.3.16.7. Strategy Overview
    • 22.3.17. TOKO
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.17.4. Sales Footprint
      • 22.3.17.5. Key Financials
      • 22.3.17.6. SWOT Analysis
      • 22.3.17.7. Strategy Overview
    • 22.3.18. Okamoto Corporation
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.18.4. Sales Footprint
      • 22.3.18.5. Key Financials
      • 22.3.18.6. SWOT Analysis
      • 22.3.18.7. Strategy Overview
    • 22.3.19. Zhejiang Sameri
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.19.4. Sales Footprint
      • 22.3.19.5. Key Financials
      • 22.3.19.6. SWOT Analysis
      • 22.3.19.7. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!